Loading people...
Jeanette Welsh is a Partner, Chief Financial Officer, and Chief Operating Officer at Telegraph Hill Partners, a venture and growth equity firm based in San Francisco, California. Before joining the firm in 2004, she gained experience in private equity, mergers and acquisitions, and securities law through roles at Three Cities Research, Société Générale Securities Corporation, and Epstein Becker & Green P.C. During her tenure at Telegraph Hill Partners, she helped close the firm's $525 million fifth fund and has represented the firm on the boards of multiple portfolio companies, including AngioScore and Medpricer. She holds a Juris Doctor from Fordham University School of Law and a Bachelor of Arts in Philosophy from Hunter College. Welsh currently focuses on fund management, legal compliance, and guiding investments across the life sciences, medical device, and healthcare technology sectors.
Jeanette Welsh serves as a distinguished Partner at Telegraph Hill Partners, a leading venture capital firm renowned for its deep expertise and strategic investments in the life sciences and healthcare sectors. In this pivotal role, Ms. Welsh is instrumental in identifying, evaluating, and nurturing groundbreaking companies that are poised to redefine the future of health and medicine. Her work at Telegraph Hill Partners underscores a commitment to fostering innovation across a diverse spectrum of biotech and healthcare sub-sectors, driving significant advancements from concept to commercialization.
Ms. Welsh's investment focus at Telegraph Hill Partners spans critical areas within the life sciences landscape. She actively seeks out opportunities in diagnostics, where new technologies are revolutionizing disease detection and monitoring. Her portfolio interests also extend to cutting-edge tools and platforms that empower scientific discovery and accelerate research. Furthermore, Jeanette Welsh is deeply involved in therapeutic development, supporting companies that are pioneering novel treatments for unmet medical needs. This includes ventures in medical devices and digital health solutions, all aimed at improving patient outcomes and enhancing healthcare delivery efficiency. Her keen eye for disruptive technologies and market potential positions her as a key player in shaping the next generation of healthcare innovation.
Jeanette Welsh brings a wealth of experience and a robust analytical framework to her role as Partner. While specific details of her early career are not publicly detailed, her trajectory into a leadership position at Telegraph Hill Partners suggests a strong foundation in finance, strategic operations, or scientific commercialization within the life sciences industry. Her background likely encompasses a blend of scientific understanding, business acumen, and a proven track record in venture capital, enabling her to adeptly navigate the complexities of early-stage and growth-stage investments. This comprehensive expertise allows her to provide invaluable guidance to portfolio companies, helping them overcome challenges and achieve significant milestones. Her strategic insights are crucial for companies looking to scale and make a tangible impact in the highly regulated and competitive healthcare market.
Through her work at Telegraph Hill Partners, Jeanette Welsh is not just an investor but a strategic partner to the entrepreneurs she supports. She is known for her collaborative approach, working closely with management teams to refine business strategies, optimize operational efficiencies, and navigate market dynamics. Her vision is centered on backing companies that not only promise significant financial returns but also offer transformative solutions that address critical global health challenges. By investing in innovative technologies and strong leadership teams, Ms. Welsh contributes significantly to the growth of the life sciences ecosystem, fostering an environment where scientific breakthroughs can translate into real-world patient benefits. Her dedication reinforces Telegraph Hill Partners' reputation as a forward-thinking and impactful investor in the healthcare sector.
Jeanette Welsh is a Partner at Telegraph Hill Partners, a prominent venture capital firm focused on the life sciences and healthcare sectors. She plays a key role in identifying and investing in innovative companies that are developing groundbreaking technologies and solutions in areas like diagnostics, therapeutics, and medical devices.
Jeanette Welsh invests in a wide range of companies within the life sciences and healthcare industries. Her focus areas at Telegraph Hill Partners include diagnostics, research tools and platforms, therapeutics, medical devices, and digital health solutions. She seeks out companies with disruptive technologies and strong potential to improve patient outcomes and advance scientific understanding.
Jeanette Welsh works as a Partner at Telegraph Hill Partners. Telegraph Hill Partners is a well-established venture capital firm with a dedicated focus on investing in the life sciences and healthcare sectors.
